FDA wants another panel hearing on Boston Scientific's Watchman anti-stroke device
The FDA wants to convene another advisory panel on Boston Scientific's Watchman anti-stroke heart repair device, CFO Dan Brennan told investors today in Boston, saying the development pushes the approval timeline into 2015.
Boston Scientific, Food & Drug Administration (FDA)News Well, Cardiac Implants, Regulatory/Compliance, Wall Street Beatread more
Source: Mass Device - Category: Medical Equipment Authors: Brad Perriello Source Type: news